Capricor Therapeutics Inc.

01/25/2022 | Press release | Distributed by Public on 01/25/2022 05:05

Capricor Therapeutics and Nippon Shinyaku Enter Partnership for Exclusive Commercialization and Distribution of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy in the[...]